Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
Johnson and Johnson
QuintilesIMS
Express Scripts
Cipla
Fish and Richardson

Generated: June 26, 2019

DrugPatentWatch Database Preview

AMANTADINE HYDROCHLORIDE - Generic Drug Details

Try a free trialSee Plans and Pricing

« Back to Dashboard

What are the generic drug sources for amantadine hydrochloride and what is the scope of amantadine hydrochloride freedom to operate?

Amantadine hydrochloride is the generic ingredient in five branded drugs marketed by Adamas Pharma, Actavis Elizabeth, Alembic Pharms Ltd, Bionpharma Inc, Graviti Pharms, Heritage Pharma, Lannett Co Inc, Sandoz, Strides Pharma, Usl Pharma, Watson Labs, Watson Labs Inc, Zydus Pharms, Solvay, Endo Pharms, Cmp Pharma Inc, G And W Labs Inc, Hi Tech Pharma, Mikart, Pharm Assoc, Teva Pharms, Vintage, Wockhardt Bio Ag, Osmotica Pharm, and Jubilant Generics, and is included in thirty-two NDAs. There are eighteen patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Amantadine hydrochloride has thirty-three patent family members in ten countries.

There are seven drug master file entries for amantadine hydrochloride. Forty-six suppliers are listed for this compound.

Pharmacology for AMANTADINE HYDROCHLORIDE
Medical Subject Heading (MeSH) Categories for AMANTADINE HYDROCHLORIDE
Synonyms for AMANTADINE HYDROCHLORIDE
(3R,5S,7s)-Adamantan-1-amine hydrochloride
(3s,5s,7s)-adamantan-1-amine hydrochloride
1-Adamantanamin Hydrochlorid
1-Adamantanamine HCl
1-Adamantanamine hydrochloride
1-Adamantanamine hydrochloride, 99+%
1-Adamantanamine hydrochloride; 1-Adamantylamine hydrochloride; 1-Aminoadamantane hydrochloride
1-Adamantanamine, hydrochloride
1-Adamantanaminehydrochloride
1-Adamantylamine hydrochloride
1-aminoada- mantane hydrochloride
1-Aminoadamantane hydrochloride
1-Aminoadamantene hydrochloride
13878-11-0
665-66-7
768-94-5 (Parent)
A 1260
A0588
A3A501
AB0014024
AB1008533
AC-8689
AC1L20JO
ACMC-209nvq
Adamantamine hydrochloride
adamantan-1-amine hydrochloride
adamantan-1-amine;hydrochloride
adamantan-1-aminium chloride
Adamantanamine HCl
Adamantanamine hydrochloride
adamantanylamine, chloride
Adamantine hydrochloride
adamantyl amine hydrochloride
Adamantylamine hydrochloride
Adamin
Adamine
ADS-5101
ADS-5102
AI3-52211
AK-40714
AKOS015900347
AKOS015951188
Amantadine (hydrochloride)
Amantadine HCl
Amantadine hydrochloride (JP17/USP)
Amantadine hydrochloride (Symmetrel)
Amantadine hydrochloride [USAN:JAN]
Amantadine hydrochloride [USAN:USP:JAN]
Amantadine hydrochloride, European Pharmacopoeia (EP) Reference Standard
Amantadine hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material
Amantadine hydrochloride, United States Pharmacopeia (USP) Reference Standard
Amantan
amantidine hydrochloride
Amazolon
Aminoadamantane hydrochloride
AN-7740
ANW-35220
AOB5792
BC204764
BCP11857
C07939
CA-1982
CCG-38899
Cerebramed
CHEBI:2619
CHEMBL1255870
CHEMBL1569
CPD001370746
CS-2502
CTK2F3028
D00777
EBD2156754
EC 211-560-2
EINECS 211-560-2
EU-0100004
EXP 105-1
Exp-105-1
F3111-1111
FT-0622248
GP 38026
HMS1920A19
Hofcomant
HY-B0402A
I14-0454
Influenol
J-650095
J-650235
K091
KB-11068
KS-000009I7
KSC353A2R
LP00004
LS-14931
Lysovir
M6Q1EO9TD0
Mantadan
Mantadine
Mantadix
MCULE-2948891352
MFCD00074723
MFCD00074723 (98%)
Midantan
Midantane
MLS000028731
MLS002153257
MLS003899199
MolPort-000-692-440
MolPort-003-925-531
MolPort-038-942-500
Mydantane
N04BB01
NC00489
NCGC00093531-01
NCGC00093531-02
NCGC00093531-03
NCGC00093531-04
NCGC00260689-01
NSC 83653
NSC-755860
NSC-83653
NSC755860
NSC83653
Nurelin
Opera_ID_671
Pharmakon1600-01500110
PubChem6390
Q-200621
RTR-022507
s2451
SAM002554881
SBB003680
SC-06172
SCHEMBL40713
SMR000059204
SMR001370746
SPECTRUM1500110
SR-01000075353
SR-01000075353-1
ST24032190
ST50508424
STR01017
SW219892-1
SY012930
Symmetrel
Symmetrel (TN)
TL8004713
Tox21_500004
TR-022507
TRA0093399
Tricyclo(3.3.1.1(sup 3,7))decan-1-amine, hydrochloride
Tricyclo(3.3.1.1(sup 3,7))decan-1-amine, hydrochloride (9CI)
Tricyclo(3.3.1.13,7)decan-1-amine, hydrochloride
Tricyclo[3.3.1.1 3,7]decan-1-amine hydrochloride
Tricyclo[3.3.1.13, hydrochloride
Tricyclo[3.3.1.13,7]decan-1-amine hydrochloride
Tricyclo[3.3.1.13,7]decan-1-amine, hydrochloride
Tricyclodecane
Trivaline
UNII-M6Q1EO9TD0
V2452
Virasol
Viregyt
Virofral
Virosol
WLN: L66 B6 A B- C 1B ITJ BZ &GH
WOLHOYHSEKDWQH-UHFFFAOYSA-N

US Patents and Regulatory Information for AMANTADINE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sandoz AMANTADINE HYDROCHLORIDE amantadine hydrochloride CAPSULE;ORAL 071293-001 Feb 18, 1987 AB RX No Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Lannett Co Inc AMANTADINE HYDROCHLORIDE amantadine hydrochloride SYRUP;ORAL 076352-001 Sep 10, 2004 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Graviti Pharms AMANTADINE HYDROCHLORIDE amantadine hydrochloride CAPSULE;ORAL 207570-001 Sep 30, 2016 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Endo Pharms SYMMETREL amantadine hydrochloride TABLET;ORAL 018101-001 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Mikart AMANTADINE HYDROCHLORIDE amantadine hydrochloride SYRUP;ORAL 074028-001 Jun 28, 1993 AA RX No Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

Subscribe to access the full database, or try a Free Trial

Expired US Patents for AMANTADINE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Osmotica Pharm OSMOLEX ER amantadine hydrochloride TABLET, EXTENDED RELEASE;ORAL 209410-001 Feb 16, 2018 ➤ Try a Free Trial ➤ Try a Free Trial
Osmotica Pharm OSMOLEX ER amantadine hydrochloride TABLET, EXTENDED RELEASE;ORAL 209410-002 Feb 16, 2018 ➤ Try a Free Trial ➤ Try a Free Trial
Osmotica Pharm OSMOLEX ER amantadine hydrochloride TABLET, EXTENDED RELEASE;ORAL 209410-003 Feb 16, 2018 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
McKesson
Mallinckrodt
Healthtrust
Queensland Health
Covington

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.